APO Research
Talk to an analyst

APO RESEARCH · REPORT

Safety Lancets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Safety Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchSafety Lancets Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Safety Lancets Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Safety Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Safety Lancets Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Safety Lancets Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Safety Lancets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Safety Lancets include Tianjin Huahong, SteriLance Medical, Shandong Lianfa, Roche, Guangzhou iCare Medical, B. Braun, UltiMed, Terumo and Sarstedt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Safety Lancets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Safety Lancets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Safety Lancets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Safety Lancets market size, projected growth trends, production technologies, key applications, and end-use industries.

Safety Lancets Segment by Company

Tianjin Huahong

SteriLance Medical

Shandong Lianfa

Roche

Guangzhou iCare Medical

B. Braun

UltiMed

Terumo

Sarstedt

Owen Mumford

Nipro

Lifescan

ICU Medical

HTL-STREFA

HemoCue

Greiner Bio One

Cardinal Health

BD

Ascensia

ARKRAY

Safety Lancets Segment by Type

Safety Lancets with Needle

Safety Lancets with Blade

Safety Lancets Segment by Application

Hospital & Clinics

Home

Other

Safety Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Safety Lancets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Safety Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Safety Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Safety Lancets Industry Trends Table 2. Safety Lancets Industry Drivers Table 3. Safety Lancets Industry Opportunities and Challenges Table 4. Safety Lancets Industry Restraints Table 5. Global Safety Lancets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Safety Lancets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Safety Lancets Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Safety Lancets Sales Market Share by Manufacturers Table 9. Global Safety Lancets Average Sales Price (US$/K Unit) of Manufacturers (2021-2026) Table 10. Global Safety Lancets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Safety Lancets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Safety Lancets Manufacturers, Product Type & Application Table 13. Global Safety Lancets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Safety Lancets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Safety Lancets with Needle Table 17. Major Manufacturers of Safety Lancets with Blade Table 18. Global Safety Lancets Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Safety Lancets Sales by Type (2021-2026) & (M Units) Table 20. Global Safety Lancets Sales by Type (2027-2032) & (M Units) Table 21. Global Safety Lancets Sales Market Share by Type (2021-2026) Table 22. Global Safety Lancets Sales Market Share by Type (2027-2032) Table 23. Global Safety Lancets Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Safety Lancets Revenue by Type (2021-2026) & (M Units) Table 25. Global Safety Lancets Revenue by Type (2027-2032) & (M Units) Table 26. Global Safety Lancets Revenue Market Share by Type (2021-2026) Table 27. Global Safety Lancets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital & Clinics Table 29. Major Manufacturers of Home Table 30. Major Manufacturers of Other Table 31. Global Safety Lancets Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Safety Lancets Sales by Application (2021-2026) & (M Units) Table 33. Global Safety Lancets Sales by Application (2027-2032) & (M Units) Table 34. Global Safety Lancets Sales Market Share by Application (2021-2026) Table 35. Global Safety Lancets Sales Market Share by Application (2027-2032) Table 36. Global Safety Lancets Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Safety Lancets Revenue by Application (2021-2026) & (M Units) Table 38. Global Safety Lancets Revenue by Application (2027-2032) & (M Units) Table 39. Global Safety Lancets Revenue Market Share by Application (2021-2026) Table 40. Global Safety Lancets Revenue Market Share by Application (2027-2032) Table 41. Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Safety Lancets Sales by Region (2021-2026) & (M Units) Table 43. Global Safety Lancets Sales Market Share by Region (2021-2026) Table 44. Global Safety Lancets Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Safety Lancets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Safety Lancets Sales by Country (2021-2026) & (M Units) Table 48. North America Safety Lancets Sales by Country (2027-2032) & (M Units) Table 49. Europe Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Safety Lancets Sales by Country (2021-2026) & (M Units) Table 51. Europe Safety Lancets Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Safety Lancets Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Safety Lancets Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Safety Lancets Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Safety Lancets Sales by Country (2027-2032) & (M Units) Table 58. Global Safety Lancets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Safety Lancets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Safety Lancets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Safety Lancets Revenue Market Share by Region (2021-2026) Table 62. Global Safety Lancets Revenue Market Share by Region (2027-2032) Table 63. Tianjin Huahong Company Information Table 64. Tianjin Huahong Business Overview Table 65. Tianjin Huahong Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Tianjin Huahong Safety Lancets Product Portfolio Table 67. Tianjin Huahong Recent Development Table 68. SteriLance Medical Company Information Table 69. SteriLance Medical Business Overview Table 70. SteriLance Medical Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. SteriLance Medical Safety Lancets Product Portfolio Table 72. SteriLance Medical Recent Development Table 73. Shandong Lianfa Company Information Table 74. Shandong Lianfa Business Overview Table 75. Shandong Lianfa Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shandong Lianfa Safety Lancets Product Portfolio Table 77. Shandong Lianfa Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Roche Safety Lancets Product Portfolio Table 82. Roche Recent Development Table 83. Guangzhou iCare Medical Company Information Table 84. Guangzhou iCare Medical Business Overview Table 85. Guangzhou iCare Medical Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guangzhou iCare Medical Safety Lancets Product Portfolio Table 87. Guangzhou iCare Medical Recent Development Table 88. B. Braun Company Information Table 89. B. Braun Business Overview Table 90. B. Braun Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. B. Braun Safety Lancets Product Portfolio Table 92. B. Braun Recent Development Table 93. UltiMed Company Information Table 94. UltiMed Business Overview Table 95. UltiMed Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. UltiMed Safety Lancets Product Portfolio Table 97. UltiMed Recent Development Table 98. Terumo Company Information Table 99. Terumo Business Overview Table 100. Terumo Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Terumo Safety Lancets Product Portfolio Table 102. Terumo Recent Development Table 103. Sarstedt Company Information Table 104. Sarstedt Business Overview Table 105. Sarstedt Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sarstedt Safety Lancets Product Portfolio Table 107. Sarstedt Recent Development Table 108. Owen Mumford Company Information Table 109. Owen Mumford Business Overview Table 110. Owen Mumford Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Owen Mumford Safety Lancets Product Portfolio Table 112. Owen Mumford Recent Development Table 113. Nipro Company Information Table 114. Nipro Business Overview Table 115. Nipro Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Nipro Safety Lancets Product Portfolio Table 117. Nipro Recent Development Table 118. Lifescan Company Information Table 119. Lifescan Business Overview Table 120. Lifescan Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Lifescan Safety Lancets Product Portfolio Table 122. Lifescan Recent Development Table 123. ICU Medical Company Information Table 124. ICU Medical Business Overview Table 125. ICU Medical Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. ICU Medical Safety Lancets Product Portfolio Table 127. ICU Medical Recent Development Table 128. HTL-STREFA Company Information Table 129. HTL-STREFA Business Overview Table 130. HTL-STREFA Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. HTL-STREFA Safety Lancets Product Portfolio Table 132. HTL-STREFA Recent Development Table 133. HemoCue Company Information Table 134. HemoCue Business Overview Table 135. HemoCue Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. HemoCue Safety Lancets Product Portfolio Table 137. HemoCue Recent Development Table 138. Greiner Bio One Company Information Table 139. Greiner Bio One Business Overview Table 140. Greiner Bio One Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Greiner Bio One Safety Lancets Product Portfolio Table 142. Greiner Bio One Recent Development Table 143. Cardinal Health Company Information Table 144. Cardinal Health Business Overview Table 145. Cardinal Health Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cardinal Health Safety Lancets Product Portfolio Table 147. Cardinal Health Recent Development Table 148. BD Company Information Table 149. BD Business Overview Table 150. BD Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. BD Safety Lancets Product Portfolio Table 152. BD Recent Development Table 153. Ascensia Company Information Table 154. Ascensia Business Overview Table 155. Ascensia Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Ascensia Safety Lancets Product Portfolio Table 157. Ascensia Recent Development Table 158. ARKRAY Company Information Table 159. ARKRAY Business Overview Table 160. ARKRAY Safety Lancets Sales (M Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. ARKRAY Safety Lancets Product Portfolio Table 162. ARKRAY Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Safety Lancets Distributors List Table 166. Safety Lancets Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Safety Lancets Product Image Figure 2. Global Safety Lancets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Safety Lancets Market Size (2021-2032) & (US$ Million) Figure 4. Global Safety Lancets Sales (2021-2032) & (M Units) Figure 5. Global Safety Lancets Average Price (US$/K Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Safety Lancets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Safety Lancets with Needle Image Figure 9. Safety Lancets with Blade Image Figure 10. Global Safety Lancets Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Safety Lancets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Safety Lancets Sales Market Share by Type (2021-2032) Figure 13. Global Safety Lancets Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Safety Lancets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Safety Lancets Revenue Market Share by Type (2021-2032) Figure 16. Hospital & Clinics Image Figure 17. Home Image Figure 18. Other Image Figure 19. Global Safety Lancets Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Safety Lancets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Safety Lancets Sales Market Share by Application (2021-2032) Figure 22. Global Safety Lancets Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Safety Lancets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Safety Lancets Revenue Market Share by Application (2021-2032) Figure 25. North America Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Safety Lancets Sales Market Share by Country (2021-2032) Figure 27. U.S. Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Safety Lancets Sales Market Share by Country (2021-2032) Figure 32. Germany Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Safety Lancets Sales Market Share by Country (2021-2032) Figure 39. China Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Safety Lancets Sales Market Share by Country (2021-2032) Figure 47. Brazil Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Safety Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Safety Lancets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Safety Lancets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Safety Lancets Revenue (2021-2032) & (US$ Million) Figure 58. North America Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Safety Lancets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Safety Lancets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Safety Lancets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Safety Lancets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Safety Lancets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets with Needle
  • Safety Lancets with Blade
Applications
  • Hospital & Clinics
  • Home
  • Other
Companies covered
  • Tianjin Huahong
  • SteriLance Medical
  • Shandong Lianfa
  • Roche
  • Guangzhou iCare Medical
  • B. Braun
  • UltiMed
  • Terumo
  • Sarstedt
  • Owen Mumford
  • Nipro
  • Lifescan
  • ICU Medical
  • HTL-STREFA
  • HemoCue
  • Greiner Bio One
  • Cardinal Health
  • BD
  • Ascensia
  • ARKRAY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Safety Lancets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Safety Lancets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Safety Lancets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Safety Lancets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Safety Lancets Market Dynamics
  1. 2.1 Safety Lancets Industry Trends
  2. 2.2 Safety Lancets Industry Drivers
  3. 2.3 Safety Lancets Industry Opportunities and Challenges
  4. 2.4 Safety Lancets Industry Restraints
3 Safety Lancets Market by Manufacturers
  1. 3.1 Global Safety Lancets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Safety Lancets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Safety Lancets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Safety Lancets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Safety Lancets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Safety Lancets Manufacturers, Product Type & Application
  7. 3.7 Global Safety Lancets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Safety Lancets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Safety Lancets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Safety Lancets Tier 1, Tier 2, and Tier 3
4 Safety Lancets Market by Type
  1. 4.1 Safety Lancets Type Introduction
  2. 4.1.1 Safety Lancets with Needle
  3. 4.1.2 Safety Lancets with Blade
  4. 4.2 Global Safety Lancets Sales by Type
  5. 4.2.1 Global Safety Lancets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Safety Lancets Sales by Type (2021-2032)
  7. 4.2.3 Global Safety Lancets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Safety Lancets Revenue by Type
  9. 4.3.1 Global Safety Lancets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Safety Lancets Revenue by Type (2021-2032)
  11. 4.3.3 Global Safety Lancets Revenue Market Share by Type (2021-2032)
5 Safety Lancets Market by Application
  1. 5.1 Safety Lancets Application Introduction
  2. 5.1.1 Hospital & Clinics
  3. 5.1.2 Home
  4. 5.1.3 Other
  5. 5.2 Global Safety Lancets Sales by Application
  6. 5.2.1 Global Safety Lancets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Safety Lancets Sales by Application (2021-2032)
  8. 5.2.3 Global Safety Lancets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Safety Lancets Revenue by Application
  10. 5.3.1 Global Safety Lancets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Safety Lancets Revenue by Application (2021-2032)
  12. 5.3.3 Global Safety Lancets Revenue Market Share by Application (2021-2032)
6 Global Safety Lancets Sales by Region
  1. 6.1 Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Safety Lancets Sales by Region (2021-2032)
  3. 6.2.1 Global Safety Lancets Sales by Region (2021-2026)
  4. 6.2.2 Global Safety Lancets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Safety Lancets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Safety Lancets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Safety Lancets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Safety Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Safety Lancets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Safety Lancets Revenue by Region
  1. 7.1 Global Safety Lancets Revenue by Region
  2. 7.1.1 Global Safety Lancets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Safety Lancets Revenue by Region (2021-2026)
  4. 7.1.3 Global Safety Lancets Revenue by Region (2027-2032)
  5. 7.1.4 Global Safety Lancets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Safety Lancets Revenue (2021-2032)
  8. 7.2.2 North America Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Safety Lancets Revenue (2021-2032)
  11. 7.3.2 Europe Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Safety Lancets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Safety Lancets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Safety Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tianjin Huahong
  2. 8.1.1 Tianjin Huahong Company Information
  3. 8.1.2 Tianjin Huahong Business Overview
  4. 8.1.3 Tianjin Huahong Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tianjin Huahong Safety Lancets Product Portfolio
  6. 8.1.5 Tianjin Huahong Recent Developments
  7. 8.2 SteriLance Medical
  8. 8.2.1 SteriLance Medical Company Information
  9. 8.2.2 SteriLance Medical Business Overview
  10. 8.2.3 SteriLance Medical Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SteriLance Medical Safety Lancets Product Portfolio
  12. 8.2.5 SteriLance Medical Recent Developments
  13. 8.3 Shandong Lianfa
  14. 8.3.1 Shandong Lianfa Company Information
  15. 8.3.2 Shandong Lianfa Business Overview
  16. 8.3.3 Shandong Lianfa Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lianfa Safety Lancets Product Portfolio
  18. 8.3.5 Shandong Lianfa Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Safety Lancets Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Guangzhou iCare Medical
  26. 8.5.1 Guangzhou iCare Medical Company Information
  27. 8.5.2 Guangzhou iCare Medical Business Overview
  28. 8.5.3 Guangzhou iCare Medical Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guangzhou iCare Medical Safety Lancets Product Portfolio
  30. 8.5.5 Guangzhou iCare Medical Recent Developments
  31. 8.6 B. Braun
  32. 8.6.1 B. Braun Company Information
  33. 8.6.2 B. Braun Business Overview
  34. 8.6.3 B. Braun Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Safety Lancets Product Portfolio
  36. 8.6.5 B. Braun Recent Developments
  37. 8.7 UltiMed
  38. 8.7.1 UltiMed Company Information
  39. 8.7.2 UltiMed Business Overview
  40. 8.7.3 UltiMed Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 UltiMed Safety Lancets Product Portfolio
  42. 8.7.5 UltiMed Recent Developments
  43. 8.8 Terumo
  44. 8.8.1 Terumo Company Information
  45. 8.8.2 Terumo Business Overview
  46. 8.8.3 Terumo Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Terumo Safety Lancets Product Portfolio
  48. 8.8.5 Terumo Recent Developments
  49. 8.9 Sarstedt
  50. 8.9.1 Sarstedt Company Information
  51. 8.9.2 Sarstedt Business Overview
  52. 8.9.3 Sarstedt Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sarstedt Safety Lancets Product Portfolio
  54. 8.9.5 Sarstedt Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Safety Lancets Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 Nipro
  62. 8.11.1 Nipro Company Information
  63. 8.11.2 Nipro Business Overview
  64. 8.11.3 Nipro Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nipro Safety Lancets Product Portfolio
  66. 8.11.5 Nipro Recent Developments
  67. 8.12 Lifescan
  68. 8.12.1 Lifescan Company Information
  69. 8.12.2 Lifescan Business Overview
  70. 8.12.3 Lifescan Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lifescan Safety Lancets Product Portfolio
  72. 8.12.5 Lifescan Recent Developments
  73. 8.13 ICU Medical
  74. 8.13.1 ICU Medical Company Information
  75. 8.13.2 ICU Medical Business Overview
  76. 8.13.3 ICU Medical Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ICU Medical Safety Lancets Product Portfolio
  78. 8.13.5 ICU Medical Recent Developments
  79. 8.14 HTL-STREFA
  80. 8.14.1 HTL-STREFA Company Information
  81. 8.14.2 HTL-STREFA Business Overview
  82. 8.14.3 HTL-STREFA Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 HTL-STREFA Safety Lancets Product Portfolio
  84. 8.14.5 HTL-STREFA Recent Developments
  85. 8.15 HemoCue
  86. 8.15.1 HemoCue Company Information
  87. 8.15.2 HemoCue Business Overview
  88. 8.15.3 HemoCue Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 HemoCue Safety Lancets Product Portfolio
  90. 8.15.5 HemoCue Recent Developments
  91. 8.16 Greiner Bio One
  92. 8.16.1 Greiner Bio One Company Information
  93. 8.16.2 Greiner Bio One Business Overview
  94. 8.16.3 Greiner Bio One Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Greiner Bio One Safety Lancets Product Portfolio
  96. 8.16.5 Greiner Bio One Recent Developments
  97. 8.17 Cardinal Health
  98. 8.17.1 Cardinal Health Company Information
  99. 8.17.2 Cardinal Health Business Overview
  100. 8.17.3 Cardinal Health Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cardinal Health Safety Lancets Product Portfolio
  102. 8.17.5 Cardinal Health Recent Developments
  103. 8.18 BD
  104. 8.18.1 BD Company Information
  105. 8.18.2 BD Business Overview
  106. 8.18.3 BD Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BD Safety Lancets Product Portfolio
  108. 8.18.5 BD Recent Developments
  109. 8.19 Ascensia
  110. 8.19.1 Ascensia Company Information
  111. 8.19.2 Ascensia Business Overview
  112. 8.19.3 Ascensia Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Ascensia Safety Lancets Product Portfolio
  114. 8.19.5 Ascensia Recent Developments
  115. 8.20 ARKRAY
  116. 8.20.1 ARKRAY Company Information
  117. 8.20.2 ARKRAY Business Overview
  118. 8.20.3 ARKRAY Safety Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ARKRAY Safety Lancets Product Portfolio
  120. 8.20.5 ARKRAY Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Safety Lancets Value Chain Analysis
  2. 9.1.1 Safety Lancets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Safety Lancets Production Mode & Process
  6. 9.2 Safety Lancets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Safety Lancets Distributors
  9. 9.2.3 Safety Lancets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst